Atorvastatin in Acute Stroke Treatment

Completed

Phase 4 Results N/A

Summary of Purpose

Recent clinical trials and meta-analyses of b-hydroxy-bmethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have demonstrated a significant reduction in ischemic stroke in patients with a history of coronary artery disease, both with and without elevations of serum cholesterol. Recent data suggest that statins have other beneficial properties in addition to the retardation of atherosclerosis. Asahi...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 August 2014.

1 Nov 2011 11 Mar 2014 1 Jan 2014 1 Mar 2014 1 Aug 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available